Insights On Regulatory Compliance

  1. Tips For Viral Vector Production 4/16/2024

    Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.

  2. Delving Into Gene Expression Data Analysis And Experimental Reproducibility 3/5/2026

    Scientific reproducibility is essential for credible research. Learn to navigate standardized frameworks, refine normalization techniques, and ensure your data remains transparent and verifiable.

  3. Elevating Environmental Monitoring Trending: From Data To Insight 2/12/2026

    Move beyond raw data by using heat maps and site-specific limits to identify contamination hotspots. Transform your environmental monitoring into a proactive strategy for operational excellence.

  4. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

    Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

  5. Filling The Sterility Testing Gap: Traceability And 21 CFR Part 11 Compliance 6/6/2024

    Watch to learn about a solution that offers digital information for every stage of a sterility test while remaining compliant with 21 CFR Part 11.

  6. Project Management: The Secret Weapon In Effective Tech Transfer 5/23/2024

    Explore how a CMO with innovative practices and a successful approach to tech transfer and manufacturing processes can help meet project timelines and mitigate risk on the path to market.

  7. How To Select The Right Fill-Finish CDMO For Phase I–II 3/16/2026

    Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

  8. De-Risking The Transition From Vial To Drug-Device Combination Product 7/25/2025

    When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

  9. Regulatory Brief: USP 382 Updates 3/17/2026

    As regulations continue to shift, staying current with the latest expectations is essential for maintaining compliance and ensuring patient safety.

  10. Molecular Approaches To Streamline Cell Therapy Product Analytical Testing 9/26/2025

    Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.